ChromaVision Medical Systems Inc., a San Juan Capistrano manufacturer of automated cell-imaging systems, said Wednesday that it has obtained $12.5 million in additional funding through the sale of preferred stock and warrants to a private investor group.
The company said in a news release that the group is headed by Halifax Fund LP, which is managed by The Palladin Group, and that other investors include Safeguard Scientifics, currently ChromaVision's largest shareholder.
